Search research articles
Contact Us
Filters
Showing results (81-90 of 103) with videos related to
Page
of 11
Sort By:
Neuro-Oncology
|
January 18, 2014
A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool
Lorea Manterola, Elizabeth Guruceaga, Jaime Gállego Pérez-Larraya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2020
Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNET
Marc Garcia-Moure, Marisol Gonzalez-Huarriz, Sara Labiano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 13, 2018
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
Frederick F Lang, Charles Conrad, Candelaria Gomez-Manzano, et al.
Cell Reports
|
November 23, 2017
GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma
Marta Moreno, Leire Pedrosa, Laia Paré, et al.
JCI Insight
|
April 8, 2022
Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas
Virginia Laspidea, Montserrat Puigdelloses, Sara Labiano, et al.
Cell Reports. Medicine
|
June 27, 2025
Targeting the CD40 costimulatory receptor to improve virotherapy efficacy in diffuse midline gliomas
Sara Labiano, Javier Marco-Sanz, Iker Ausejo-Mauleon, et al.
Neuro-Oncology
|
January 27, 2018
The aberrant splicing of BAF45d links splicing regulation and transcription in glioblastoma
Guillermo Aldave, Marisol Gonzalez-Huarriz, Angel Rubio, et al.
Cancer Cell
|
March 24, 2026
Radiotherapy synergizes with an inducible AAV-based immunotherapy platform to program local and systemic antitumor immunity
Sonia Marco, Myriam Fernández, Beatriz Honorato, et al.
Nature Communications
|
May 30, 2019
The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models
Naiara Martínez-Vélez, Marc Garcia-Moure, Miguel Marigil, et al.
Neuro-Oncology
|
March 30, 2024
The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models
Daniel de la Nava, Iker Ausejo-Mauleon, Virginia Laspidea, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 103) with videos related to
Sort By:
Page
of 11
Neuro-Oncology
|
January 18, 2014
A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool
Lorea Manterola, Elizabeth Guruceaga, Jaime Gállego Pérez-Larraya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2020
Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNET
Marc Garcia-Moure, Marisol Gonzalez-Huarriz, Sara Labiano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 13, 2018
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
Frederick F Lang, Charles Conrad, Candelaria Gomez-Manzano, et al.
Cell Reports
|
November 23, 2017
GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma
Marta Moreno, Leire Pedrosa, Laia Paré, et al.
JCI Insight
|
April 8, 2022
Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas
Virginia Laspidea, Montserrat Puigdelloses, Sara Labiano, et al.
Cell Reports. Medicine
|
June 27, 2025
Targeting the CD40 costimulatory receptor to improve virotherapy efficacy in diffuse midline gliomas
Sara Labiano, Javier Marco-Sanz, Iker Ausejo-Mauleon, et al.
Neuro-Oncology
|
January 27, 2018
The aberrant splicing of BAF45d links splicing regulation and transcription in glioblastoma
Guillermo Aldave, Marisol Gonzalez-Huarriz, Angel Rubio, et al.
Cancer Cell
|
March 24, 2026
Radiotherapy synergizes with an inducible AAV-based immunotherapy platform to program local and systemic antitumor immunity
Sonia Marco, Myriam Fernández, Beatriz Honorato, et al.
Nature Communications
|
May 30, 2019
The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models
Naiara Martínez-Vélez, Marc Garcia-Moure, Miguel Marigil, et al.
Neuro-Oncology
|
March 30, 2024
The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models
Daniel de la Nava, Iker Ausejo-Mauleon, Virginia Laspidea, et al.
Page
of 11